The molecular mechanisms of NFE2L3 in cancer was evaluated by performing a comprehensive analysis of NFE2L3 in 33 types of human tumors based on data from the TCGA, CCLE, and HPA databases, including gene expression, epigenetic methylation, genetic alteration, functional enrichment, immune features, and survival prognosis. Here, NFE2L3 is linked to cancer.